327 related articles for article (PubMed ID: 24440764)
1. [Gastric signet ring cell adenocarcinoma: A distinct entity].
Tabouret T; Dhooge M; Rouquette A; Brezault C; Beuvon F; Chaussade S; Coriat R
Presse Med; 2014 Apr; 43(4 Pt 1):353-7. PubMed ID: 24440764
[TBL] [Abstract][Full Text] [Related]
2. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
3. Treatment issues in pediatric gastric adenocarcinoma.
Harting MT; Blakely ML; Herzog CE; Lally KP; Ajani JA; Andrassy RJ
J Pediatr Surg; 2004 Aug; 39(8):e8-10. PubMed ID: 15300556
[TBL] [Abstract][Full Text] [Related]
4. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
5. Superficially Spreading Signet-Ring Cell Carcinoma Perpendicularly Colliding with Gastric Adenoma: a Rare Case Report.
Minami T; Yuasa N; Takeuchi E; Miyake H; Nagai H; Miyata K; Kiriyama A
J Gastrointest Cancer; 2019 Sep; 50(3):609-612. PubMed ID: 29441461
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology and their impact on the surgical strategy: analysis of single institutional experience.
Wang Z; Zhang X; Hu J; Zeng W; Liang J; Zhou H; Zhou Z
J Surg Res; 2014 Sep; 191(1):130-3. PubMed ID: 24768142
[TBL] [Abstract][Full Text] [Related]
8. Multiple early gastric cancer with gastritis cystica profunda showing various histological types.
Tsuji T; Iwahashi M; Nakamori M; Ueda K; Ishida K; Naka T; Ojima T; Akamatsu H; Yamaue H
Hepatogastroenterology; 2008; 55(84):1150-2. PubMed ID: 18705349
[TBL] [Abstract][Full Text] [Related]
9. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
10. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.
Lee SH; Jee SR; Kim JH; Seol SY
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):170-4. PubMed ID: 25503738
[TBL] [Abstract][Full Text] [Related]
11. A rare case of signet ring cell gastric adenocarcinoma.
Dickey A; Hrom J
J Miss State Med Assoc; 2007 Sep; 48(9):271-5. PubMed ID: 19292116
[TBL] [Abstract][Full Text] [Related]
12. Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
Elimova E; Ajani JA
J Clin Oncol; 2015 Oct; 33(28):3085-91. PubMed ID: 26324361
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
14. A signet-ring cell carcinoma of the stomach endoscopically recognized as a tiny discolored spot.
Sanaka M; Kuyama Y; Yamanaka M; Tamura Y
Endoscopy; 1998 Oct; 30(8):S99. PubMed ID: 9865583
[No Abstract] [Full Text] [Related]
15. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma.
Lee HE; Smyrk TC; Zhang L
Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626
[TBL] [Abstract][Full Text] [Related]
16. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
17. NK cells adjuvant therapy shows survival benefits in a gastric mixed signet ring cell carcinoma patient: A case report.
Jin YY; Yang WZ; Sun ZY; Wang ZB; Chen J; Wu CT; Yang ZY
Medicine (Baltimore); 2021 Mar; 100(10):e24979. PubMed ID: 33725867
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
20. Small mucosal carcinoma of the stomach with para-aortic lymph node metastasis: a case report and review of the literature.
Miyaji M; Ogoshi K; Nakamura K; Kondo Y; Tajima T; Makuuchi H; Sato S; Osamura Y
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):343-6. PubMed ID: 10333210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]